Jinling Pharmaceutical: Prompt Announcement of Jinling Pharmaceutical Co., Ltd. on the holding of the 3rd Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the company and its subsidiaries using idle own funds to purchase wealth management products
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on changing the registered capital and amending the “Articles of Association”
Jinling Pharmaceutical: 2024 Semi-Annual Financial Report
Jinling Pharmaceutical: Semi-annual non-operating capital usage and other related capital transactions summary table
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on adjusting the positions of the company\'s senior management personnel and appointing an assistant to the company\'s president
Jinling Pharmaceutical: Notice of Jinling Pharmaceutical Co., Ltd. on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. Regarding Control Subsidiary Received Notice of Approval for Chemical Raw Material Drug Listing Application
Jinling Pharmaceutical: Announcement on the Resignation of Non-Employee Supervisors of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement on the completion of industrial and commercial changes registration for capital increase of Jinling Pharmaceutical Co., Ltd., a wholly-owned subsidiary.
Jinling Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the 2023 Annual General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on completing the registration of industrial and commercial changes
Jinling Pharmaceutical: Internal Control Self-Assessment Report
Jinling Pharmaceutical: Special instructions for securities investment
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on increasing registered capital and amending the “Articles of Association”
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the use of raised funds to increase capital for wholly-owned subsidiaries to implement fund-raising projects
Jinling Pharmaceutical: Rules of procedure for the special meeting of independent directors of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement on the progress of the company's subsidiaries using idle funds to purchase wealth management products
Jinling Pharmaceutical: Jinling Pharmaceutical Co., Ltd. 2023 Financial Results Report
No Data